Drugs / LUCORIDALINES
Trials 9 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01669772 | Mar 2012 → Feb 2013 | — | Myung-gui Choi | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02365701 | Jun 2015 → Feb 2018 | dyspepsia | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT07686679 | Jul 2026 → Oct 2027 expected | dyspepsia | Dong-A ST Co., Ltd. | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT02775591 | Apr 2016 → Jun 2018 | Parkinson disease, dyspepsia | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03022201 | May 2013 → May 2016 | Parkinson disease | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01817465 | Aug 2012 → Mar 2014 | dyspepsia | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT01719575 | Mar → Nov 2012 | — | Dong-A Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT07096921 | Jul 2025 → Mar 2026 overdue | dyspepsia | Eunpyeong St. Mary's Hospital | Active not recruiting | No outcome recorded |
| — | NCT02162316 | Jul 2014 → Jun 2015 | dyspepsia | Chung-Ang University Hospital | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02533349 Comparator | May → Dec 2016 | gastroesophageal reflux disease | Samsung Medical Center | Unknown | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT04350346 Comparator | Mar 2020 → Sep 2021 | gallstones | Yonsei University | Unknown | No outcome recorded |
| — | NCT02151708 Comparator | Jun 2014 → Feb 2015 | dyspepsia | Samsung Medical Center | Unknown | No outcome recorded |
| — | NCT02091635 Comparator | Aug → Oct 2013 | dyspepsia | Samsung Medical Center | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 14 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LUCORIDALINES | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314637 ↗ |
| Known as | DA-9701 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02775591 ↗ |
| Known as | motilitone | “Prescribe 30mg of DA-9701(motilitone) t.i.d for 1 week and then crossover to placebo.” NCT01669772 ↗ |
| Action | Activate | “It stimulates 5-HT4 receptor as a gastrointestinal motility accelerator to increase acetylcholine secretion and contract smooth muscle.” NCT04350346 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “DA-9701 (Motilitone) is recently developed herbal medication” NCT02775591 ↗ |
| Route | Oral | “in tablet form, to be taken 3 times daily” NCT02365701 ↗ |